FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2298046728> ?p ?o ?g. }

• W2298046728 endingPage "2971" @default.
• W2298046728 startingPage "2971" @default.
• W2298046728 abstract "To explore the synergistic effect of docosahexaenoic acid (DHA)/5-fluorouracil (5-FU) on the human gastric cancer cell line AGS and examine the underlying mechanism.AGS cells were cultured and treated with a series of concentrations of DHA and 5-FU alone or in combination for 24 and 48 h. To investigate the synergistic effect of DHA and 5-FU on AGS cells, the inhibition of cell proliferation was determined by MTT assay and cell morphology. Flow cytometric analysis was also used to assess cell cycle distribution, and the expression of mitochondrial electron transfer chain complexes (METCs) I, II and V in AGS cells was further determined by Western blot analysis.DHA and 5-FU alone or in combination could markedly suppress the proliferation of AGS cells in a significant time and dose-dependent manner. DHA markedly strengthened the antiproliferative effect of 5-FU, decreasing the IC50 by 3.56-2.15-fold in an apparent synergy. The morphological changes of the cells were characterized by shrinkage, cell membrane blebbing and decreased adherence. Cell cycle analysis showed a shift of cells into the G0/G1 phase from the S phase following treatment with DHA or 5-FU (G0/G1 phase: 30.04% ± 1.54% vs 49.05% ± 6.41% and 63.39% ± 6.83%, respectively, P < 0.05; S phase: 56.76% ± 3.14% vs 34.75% ± 2.35% and 25.63% ± 2.21%, respectively, P < 0.05). Combination treatment of DHA and 5-FU resulted in a significantly larger shift toward the G0/G1 phase and subsequent reduction in S phase (G0/G1 phase: 69.06% ± 2.63% vs 49.05% ± 6.41% and 63.39% ± 6.83%, respectively, P < 0.05; S phase: 19.80% ± 4.30% vs 34.75% ± 2.35% and 25.63% ± 2.21%, respectively, P < 0.05). This synergy was also reflected in the significant downregulation of the expression of METCs in AGS cells.Synergistic anticancer properties of DHA and 5-FU may involve interference with energy production of AGS cells via downregulation of METCs and cell cycle arrest." @default.
• W2298046728 created "2016-06-24" @default.
• W2298046728 creator A5000448546 @default.
• W2298046728 creator A5025793197 @default.
• W2298046728 creator A5032735164 @default.
• W2298046728 creator A5041060928 @default.
• W2298046728 creator A5079872289 @default.
• W2298046728 date "2016-01-01" @default.
• W2298046728 modified "2023-09-27" @default.
• W2298046728 title "Synergistic anticancer properties of docosahexaenoic acid and 5-fluorouracil through interference with energy metabolism and cell cycle arrest in human gastric cancer cell line AGS cells" @default.
• W2298046728 cites W12636511 @default.
• W2298046728 cites W1511042984 @default.
• W2298046728 cites W1529000504 @default.
• W2298046728 cites W1581928706 @default.
• W2298046728 cites W1968501452 @default.
• W2298046728 cites W1968516322 @default.
• W2298046728 cites W1978260286 @default.
• W2298046728 cites W1979538859 @default.
• W2298046728 cites W1982330633 @default.
• W2298046728 cites W1989827583 @default.
• W2298046728 cites W1996447891 @default.
• W2298046728 cites W2005729354 @default.
• W2298046728 cites W2007928899 @default.
• W2298046728 cites W2018061070 @default.
• W2298046728 cites W2029218654 @default.
• W2298046728 cites W2040935952 @default.
• W2298046728 cites W2047463366 @default.
• W2298046728 cites W2050721697 @default.
• W2298046728 cites W2062625249 @default.
• W2298046728 cites W2069466069 @default.
• W2298046728 cites W2072451938 @default.
• W2298046728 cites W2090174025 @default.
• W2298046728 cites W2091126984 @default.
• W2298046728 cites W2091876552 @default.
• W2298046728 cites W2115604279 @default.
• W2298046728 cites W2124690429 @default.
• W2298046728 cites W2130285474 @default.
• W2298046728 cites W2131597845 @default.
• W2298046728 cites W2135594199 @default.
• W2298046728 cites W2145220059 @default.
• W2298046728 cites W2153367437 @default.
• W2298046728 cites W2154963578 @default.
• W2298046728 cites W2158734599 @default.
• W2298046728 cites W2159171427 @default.
• W2298046728 cites W2163927713 @default.
• W2298046728 cites W2171792523 @default.
• W2298046728 cites W2380560649 @default.
• W2298046728 doi "https://doi.org/10.3748/wjg.v22.i10.2971" @default.
• W2298046728 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4779920" @default.
• W2298046728 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26973393" @default.
• W2298046728 hasPublicationYear "2016" @default.
• W2298046728 type Work @default.
• W2298046728 sameAs 2298046728 @default.
• W2298046728 citedByCount "24" @default.
• W2298046728 countsByYear W22980467282017 @default.
• W2298046728 countsByYear W22980467282018 @default.
• W2298046728 countsByYear W22980467282019 @default.
• W2298046728 countsByYear W22980467282020 @default.
• W2298046728 countsByYear W22980467282021 @default.
• W2298046728 countsByYear W22980467282022 @default.
• W2298046728 countsByYear W22980467282023 @default.
• W2298046728 crossrefType "journal-article" @default.
• W2298046728 hasAuthorship W2298046728A5000448546 @default.
• W2298046728 hasAuthorship W2298046728A5025793197 @default.
• W2298046728 hasAuthorship W2298046728A5032735164 @default.
• W2298046728 hasAuthorship W2298046728A5041060928 @default.
• W2298046728 hasAuthorship W2298046728A5079872289 @default.
• W2298046728 hasBestOaLocation W22980467281 @default.
• W2298046728 hasConcept C105696609 @default.
• W2298046728 hasConcept C121608353 @default.
• W2298046728 hasConcept C126322002 @default.
• W2298046728 hasConcept C1491633281 @default.
• W2298046728 hasConcept C153911025 @default.
• W2298046728 hasConcept C185592680 @default.
• W2298046728 hasConcept C190283241 @default.
• W2298046728 hasConcept C19038510 @default.
• W2298046728 hasConcept C2777171753 @default.
• W2298046728 hasConcept C2780783641 @default.
• W2298046728 hasConcept C29537977 @default.
• W2298046728 hasConcept C543025807 @default.
• W2298046728 hasConcept C54355233 @default.
• W2298046728 hasConcept C553184892 @default.
• W2298046728 hasConcept C55493867 @default.
• W2298046728 hasConcept C62112901 @default.
• W2298046728 hasConcept C71924100 @default.
• W2298046728 hasConcept C81885089 @default.
• W2298046728 hasConcept C86803240 @default.
• W2298046728 hasConcept C96232424 @default.
• W2298046728 hasConcept C98274493 @default.
• W2298046728 hasConceptScore W2298046728C105696609 @default.
• W2298046728 hasConceptScore W2298046728C121608353 @default.
• W2298046728 hasConceptScore W2298046728C126322002 @default.
• W2298046728 hasConceptScore W2298046728C1491633281 @default.
• W2298046728 hasConceptScore W2298046728C153911025 @default.
• W2298046728 hasConceptScore W2298046728C185592680 @default.
• W2298046728 hasConceptScore W2298046728C190283241 @default.
• W2298046728 hasConceptScore W2298046728C19038510 @default.
• W2298046728 hasConceptScore W2298046728C2777171753 @default.

• next